共 50 条
[21]
Management of Diabetic Retinopathy in the Anti-Vascular Endothelial Growth Factor Era
[J].
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES,
2021, 41 (03)
:461-463
[26]
RATES AND RISK FACTORS FOR RECURRENCE OF RETINOPATHY OF PREMATURITY AFTER LASER OR INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR MONOTHERAPY
[J].
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES,
2020, 40 (09)
:1793-1803
[27]
REPORT OF SAFETY OF THE USE OF A SHORT 32G NEEDLE FOR INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS FOR RETINOPATHY OF PREMATURITY
[J].
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES,
2018, 38 (06)
:1251-1255
[29]
Efficacy of four anti-vascular endothelial growth factor agents and laser treatment for retinopathy of prematurity: A network meta-analysis
[J].
BIOMOLECULES AND BIOMEDICINE,
2024, 24 (04)
:676-687
[30]
FLUORESCEIN ANGIOGRAPHY EVALUATION OF CHILDREN PREVIOUSLY TREATED WITH ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR MONOTHERAPY FOR RETINOPATHY OF PREMATURITY
[J].
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES,
2024, 44 (05)
:901-908